CARY, N.C.--(BUSINESS WIRE)--Biologics, an integrated oncology services company, is excited to announce that Eli Lilly has selected its Oncology Pharmacy Services to be the exclusive specialty pharmacy provider of CYRAMZA™ (ramucirumab). In addition to accessing the drug via specialty distribution, Eli Lilly made the decision to offer physicians and healthcare practices the opportunity to order CYRAMZA™ through Biologics as an alternative option.
Help employers find you! Check out all the jobs and post your resume.
